CKM and hypertriglyceridemia: In the exploratory reverse cohort, baseline MASLD was associated with CKM stage progression in the age- and sex-adjusted model (HR = 2.13, 95% CI: 1.49-3.03), but this association attenuated after adjustment for baseline BMI (HR = 1.18, 95% CI: 0.81-1.71).<h4>Conclusion</h4>Metabolic-dimension CKM staging and CM component burden predicted incident MASLD, with excess adiposity and <b>hypertriglyceridaemia</b> as dominant component-level predictors.